win 52035 has been researched along with disoxaril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, TR; Diana, GD; Dutko, FJ; Oglesby, RC; Pevear, DC; Treasurywala, AM | 1 |
| Akullian, V; Diana, GD; McKinlay, MA; Oglesby, C; Otto, MJ | 1 |
| Akullian, V; Carabateas, PM; Cutcliffe, D; Diana, GD; Maliski, EG; Mallamo, JP; McKinlay, MA; Michalec, SJ; Oglesby, RC; Otto, MJ | 1 |
| Abraham, U; Klebe, G | 1 |
| Cedergren, R; Leclerc, F | 1 |
| Egorova, A; Ekins, S; Makarov, V; Schmidtke, M | 1 |
| Badger, J; Dutko, FJ; Fancher, M; Heinz, BA; McKinlay, MA; Rossmann, MG; Rueckert, RR; Shepard, DA; Smith, TJ | 1 |
1 review(s) available for win 52035 and disoxaril
| Article | Year |
|---|---|
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
Topics: Antiviral Agents; Binding Sites; Capsid; Dose-Response Relationship, Drug; Enterovirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2019 |
6 other study(ies) available for win 52035 and disoxaril
| Article | Year |
|---|---|
A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
Topics: Antiviral Agents; Binding Sites; Capsid; Isoxazoles; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Rhinovirus; Structure-Activity Relationship; X-Ray Diffraction | 1990 |
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Isoxazoles; Mice; Oxazoles; Picornaviridae Infections; Poliovirus; Rhinovirus; Structure-Activity Relationship; Time Factors; Virus Replication | 1985 |
Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
Topics: Antiviral Agents; Humans; Indicators and Reagents; Isoxazoles; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Oxazoles; Rhinovirus; Species Specificity; Structure-Activity Relationship | 1987 |
On the prediction of binding properties of drug molecules by comparative molecular field analysis.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Crystallography; Drug Design; Humans; Molecular Conformation; Molecular Sequence Data; Reference Standards; Renin; Rhinovirus; Thermolysin | 1993 |
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antiviral Agents; Binding Sites; Computer Simulation; Crystallography, X-Ray; Gene Products, rev; Humans; Ligands; Macromolecular Substances; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Protein Conformation; Rhinovirus; RNA, Viral; Structure-Activity Relationship | 1998 |
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Molecular Conformation; Molecular Structure; Mutation; Oxazoles; Rhinovirus; Viral Plaque Assay | 1989 |